What We're Reading: Page 329
Industry reads hand-picked by our editors
Apr 08, 2016
-
FierceBiotech
FDA reviewers question efficacy, raise safety issues and cite a challenge on Clovis's rociletinib
-
PMLive
BMS' Opdivo gets two new indications in Europe
-
Bloomberg
Valeant Shares Have Best Three-Day Run in Almost 20 Years
-
Reuters
Suit that mimics life at age 85 has no creases, just creaks
Apr 07, 2016
Apr 06, 2016
Apr 05, 2016
-
The Street
Allergan Could Buy These Drug Companies if the Pfizer Merger Is Scuttled
-
ProPublica
Amid Public Feuds, A Venerated Medical Journal Finds Itself Under Attack
-
MIT Technology Review
The Rogue Immune Cells That Wreck the Brain
-
Reuters
Boston Scientific says suspends Watchman FLX sales in Europe
Previous
